Zoetis Inc. (ZTS) Financial Statements (2024 and earlier)

Company Profile

Business Address 10 SYLVAN WAY
PARSIPPANY, NJ 07054
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 1,7541,7172,109 2,507
Cash and cash equivalents 1,7541,7172,109 2,507
Restricted cash and investments 2   4 
Receivables1,3621,2571,3221,1861,2861,189
Inventory, net of allowances, customer advances and progress billings2,5642,7442,7012,5632,3452,303
Inventory2,5642,7442,7012,5632,3452,303
Other current assets434467443411365552
Other undisclosed current assets 1,981   3,506 
Total current assets:6,3436,2226,1836,2697,5066,551
Noncurrent Assets
Operating lease, right-of-use asset230226224216220217
Property, plant and equipment3,2043,0923,0112,9132,7532,623
Intangible assets, net (including goodwill)4,0974,1603,9664,0524,1264,011
Goodwill2,7592,7622,7142,7382,7462,692
Intangible assets, net (excluding goodwill)1,3381,3981,2521,3141,3801,319
Deferred income tax assets206190192161173111
Other noncurrent assets206216173143147161
Total noncurrent assets:7,9437,8847,5667,4857,4197,123
TOTAL ASSETS:14,28614,10613,74913,75414,92513,674
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0941,5091,6601,8081,0871,734
Taxes payable84
Employee-related liabilities257
Accounts payable411388464424405373
Accrued liabilities6831,1211,1961,3846821,020
Debt42231,3521,353
Other liabilities1029710710497134
Other undisclosed current liabilities 689   631(341)
Total current liabilities:1,8891,6081,7691,9153,1672,880
Noncurrent Liabilities
Long-term debt and lease obligation6,5646,5526,5556,5596,5525,396
Long-term debt, excluding current maturities6,5646,5526,5556,5596,5525,210
Liabilities, other than long-term debt842872804789803736
Accounts payable and accrued liabilities271262278262258241
Deferred income tax liabilities146160121131142256
Other liabilities237259217216217239
Operating lease, liability188191188180186186
Total noncurrent liabilities:7,4067,4247,3597,3487,3556,132
Total liabilities:9,2959,0329,1289,26310,5229,012
Equity
Equity, attributable to parent4,9975,0784,6254,4944,4054,663
Common stock555555
Treasury stock, value(5,597)(5,369)(5,126)(4,807)(4,539)(4,139)
Additional paid in capital1,1331,1161,0981,0791,0881,073
Accumulated other comprehensive loss(839)(814)(895)(828)(817)(809)
Retained earnings10,29510,1409,5439,0458,6688,533
Equity, attributable to noncontrolling interest(6)(4)(4)(3)(2)(1)
Total equity:4,9915,0744,6214,4914,4034,662
TOTAL LIABILITIES AND EQUITY:14,28614,10613,74913,75414,92513,674

Income Statement (P&L) ($ in millions)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Revenues2,2132,1512,1802,0002,0402,002
Cost of revenue
(Cost of Goods and Services Sold)
(728)(638)(607)(588)(653)(607)
Gross profit:1,4851,5131,5731,4121,3871,395
Operating expenses(739)(677)(702)(647)(662)(635)
Operating income:746836871765725760
Nonoperating income (expense)8(6)10453(34)3
Investment income, nonoperating1113411
Loss, foreign currency transaction, before tax(6)(19)(13)(9)(26)(11)
Other nonoperating income (expense)5(4)2(5)61
Interest and debt expense(59)(59)(58)(63)(62)(53)
Income from continuing operations before equity method investments, income taxes:695771917755629710
Other undisclosed loss from continuing operations before income taxes(45)(54)(45)(58)(37)(43)
Income from continuing operations before income taxes:650717872697592667
Income tax expense(127)(121)(202)(146)(132)(139)
Income from continuing operations:523596670551460528
Income before gain (loss) on sale of properties:528
Net income:523596670551460528
Net income attributable to noncontrolling interest 2 1111
Net income available to common stockholders, diluted:525596671552461529

Comprehensive Income ($ in millions)

3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
Net income:523596670551460528
Other comprehensive income (loss)(25)81(67)(11)(8)(87)
Comprehensive income:498677603540452441
Comprehensive income, net of tax, attributable to noncontrolling interest 2 1111
Comprehensive income, net of tax, attributable to parent:500677604541453442

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: